Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

14.33

-0.22 (-1.51%)

At close: Jun 27, 2025, 4:00 PM

14.00

-0.33 (-2.30%)

After-hours: Jun 27, 2025, 5:55 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Monoclonal Antibody	302.00K	Log In	Log In	Log In	Log In	Upgrade
Monoclonal Antibody Growth	-3.82%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	302.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-3.82%	Log In	Log In	Log In	Log In	Upgrade